- MDPBP
- 3′,4′-Methylenedioxy-α-(pyrrolidin-1-yl)butanophenone
- 1-(2H-1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one
- 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one
Iversen, LL. Consideration of the cathinones, Advisory Council on the Misuse of Drugs, 31 Mar 2010. 286 kB.
Brandt, SD; Freeman, S; Sumnall, HR; Measham, F; Cole, JC. Analysis of NRG ‘legal highs’ in the UK: Identification and formation of novel cathinones Drug Test. Anal., 1 Sep 2011, 3 (9), 569–575. 176 kB. https://doi.org/10.1002/dta.204 #3 MS,NMR
Abiedalla, YFH; Abdel-Hay, KM; DeRuiter, J; Clark, CR. Synthesis and GC-MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV) Forensic Sci. Int., 30 Nov 2012, 223 (1–3), 189–197. 657 kB. https://doi.org/10.1016/j.forsciint.2012.08.040 #4 GC,MS
Zuba, D. Identification of cathinones and other active components of ‘legal highs’ by mass spectrometric methods Trends Anal. Chem., 1 Feb 2012, 32, 15–30. 576 kB. https://doi.org/10.1016/j.trac.2011.09.009 MS
Zuba, D; Byrska, B. Prevalence and co-existence of active components of ‘legal highs’ Drug Test. Anal., 1 Jun 2013, 5 (6), 420–429. 1.3 MB. https://doi.org/10.1002/dta.1365
EMCDDA. New drugs in Europe, 2010, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2011. 700 kB.
Leffler, AM; Smith, PB; de Armas, A; Dorman, FL. The analytical investigation of synthetic street drugs containing cathinone analogs Forensic Sci. Int., 1 Jan 2014, 234, 50-56. 973 kB. https://doi.org/10.1016/j.forsciint.2013.08.021 MS
Westphal, F; Junge, T; Klein, B; Fritschi, G; Girreser, U. Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: A new designer drug with α-pyrrolidinophenone structure Forensic Sci. Int., 1 Jun 2011, 209 (1-3), 126-132. 610 kB. https://doi.org/10.1016/j.forsciint.2011.01.016 #1 MS,NMR,IR
Kavanagh, PV; Power, JD. New psychoactive substances legislation in Ireland – Perspectives from academia Drug Test. Anal., 1 Jul 2014, 6 (7-8), 884-891. 1.2 MB. https://doi.org/10.1002/dta.1598
Fornal, E. Study of collision-induced dissociation of electrospray-generated protonated cathinones Drug Test. Anal., 1 Jul 2014, 6 (7-8), 705-715. 527 kB. https://doi.org/10.1002/dta.1573 #36 MS
Nagashima, M; Suzuki, J; Moriyasu, T; Yoshida, M; Shimizu, M; Hamano, T; Nakae, D. Analysis of uncontrolled drugs purchased in the fiscal year 2010 Ann. Rep. Tokyo Metr. Inst. P. H., 1 Jan 2011, 62 99–105. 889 kB. #MDPBP LC,MS,NMR,UV,other
Rickli, A; Hoener, MC; Liechti, ME. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones Eur. Neuropsychopharmacol., 1 Mar 2015, 25 (3), 365–376. 1.6 MB. https://doi.org/10.1016/j.euroneuro.2014.12.012 #MDPBP
Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Cathinones MDPBP
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #MDPBP
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. A method for identifying designer drugs of synthetic cathinones JCCL, 1 Dec 2015, (55), 17–41. 663 kB. #14 Japanese, English abstract MS,NMR,IR,UV
Gatch, MB; Forster, MJ. Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats J. Psychopharmacol., 1 Jul 2020, 34 (7), 778-785. 546 kB. https://doi.org/10.1177/0269881120914213 #MDPBP
Chen, Y; Canal, CE. Structure–activity relationship study of psychostimulant synthetic cathinones reveals nanomolar antagonist potency of α-pyrrolidinohexiophenone at human muscarinic M2 receptors ACS Chem. Neurosci., 18 Mar 2020, 11 (6), 960–968. 1.2 MB. https://doi.org/10.1021/acschemneuro.0c00008 #MDPBP